FOR IMMEDIATE RELEASE:
December 7, 2009
CONTACT: Aaron Tallent
571-483-1371
aaron.tallent@asco.org
ALEXANDRIA, Va. – The
Journal of Clinical Oncology (JCO) announced today that Stephen A. Cannistra, MD, Professor of Medicine at Harvard Medical School, will become Editor-in-Chief of
JCO effective May 2011.
“We are delighted with the choice of Dr. Cannistra as the next Editor-in-Chief of JCO,” said Douglas W. Blayney, MD, President of the American Society of Clinical Oncology (ASCO). “His clinical, research and editorial experience give him insights into the needs of ASCO members and JCO readers that will guide his editorial decisions and allow him to build on the excellence for which the journal is known.”
Having served JCO in various capacities, including reviewer, associate editor, consultant editor and Editorial Board Member since 1989, Dr. Cannistra brings a strong knowledge of the journal’s history, mission, structure and operations. He will replace Daniel G. Haller, MD, who will complete his second term as Editor-in-Chief of JCO in May 2011. During Dr. Haller’s tenure, JCO’s impact factor (which measures the frequency with which the "average article" in a journal has been cited) has increased from 8.773 in 2001 to 17.157.
“I am honored to be named to this position and hope to build on the superb leadership of Dr. Haller,” said Dr. Cannistra. “As Editor-in-Chief of JCO, I look forward to seeking out ways to maximize our ability to attract the best practice-changing and population-based oncology research and play a greater educational role in the process of clinical investigation.”
In addition to his professorship at Harvard Medical School, Dr. Cannistra serves as Director of Gynecologic Medical Oncology at Beth Israel-Deaconess Medical Center and is Co-Leader of the Dana-Farber/Harvard Cancer Center disease program in Gynecologic Oncology. He has had a longstanding commitment to basic science, clinical investigation, and translational research in ovarian cancer, and also plays a major role in medical school and residency education. He has held several leadership positions in ASCO including serving on the Scientific Program Committee as chair of the Gynecologic Cancer subcommittee as well as serving as an ASCO expert on tumor biology.
Dr. Cannistra received his Bachelor of Science (1976) and Medical (1979) degrees from Brown University. He received his internship and residency training in medicine at the Johns Hopkins Hospital and subsequent fellowship training in medical oncology at the Dana-Farber Cancer Institute.
# # #
About the American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 27,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org/presscenter. Patient-oriented cancer information is available at www.cancer.net.
About the Journal of Clinical Oncology
The Journal of Clinical Oncology is the tri-monthly peer-reviewed journal of the American Society of Clinical Oncology (ASCO), the world's leading professional society representing physicians who treat people with cancer. For more information, please visit www.jco.org
